Showing 161-170 of 8348 results for "".
What Every Dermatologist Must Know About the History of Black Hair
https://practicaldermatology.com/topics/hair-nails/what-every-dermatologist-must-know-about-the-history-of-black-hair/23996/Knowledge of the historical, cultural, and social significance of hairstyles of Black patients may reduce implicit bias amongst dermatologists. In this article, Brooke Jackson, MD, FAAD, and Aliya Rodriguez, BS, explore the unique history and cultral impact of black hair.Eradicating the Itch of Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/eradicating-the-itch-of-atopic-dermatitis/23947/Emerging treatments explore alternative pathways to stop itching at the source.DermWireTV: Sun Hero Launch; Eczema Awareness Month; ASDSA Hails Hyaluron Pen Warning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sun-hero-launch-eczema-awareness-month-asdsa-hails-hyaluron-pen-warning/20006/An estimated 80% of skin damage occurs before age 18. L'Oreal brands CeraVe and LaRoche-Posay have teamed with Dr. Amy Brodsky to launch the Sun Hero campaign to educate young people about UV safety. Throughout Eczema Awareness month, the National Eczema Association is spotlighting aspects of the diWhat Every Dermatologist Should Know About AI
https://practicaldermatology.com/topics/practice-management/what-every-dermatologist-should-know-about-ai/23569/As augmented intelligence evolves, here are seven things every dermatologist should know about its potential and its limitations.DermWireTV: Arcutis Survey on PsO Impact; Tinted Sunscreen Update; Cosmetic Interventions and Illness; Dr. Seemal Desai Elected
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-arcutis-survey-on-pso-impact-tinted-sunscreen-update-cosmetic-interventions-and-illness-dr-seema-desai-elected/20089/Arcutis Biotherapeutics' survey finds Individuals with psoriasis who use topical treatments want more effective and simpler interventions. Intertriginous disease poses particular challenges. Increased availability of tinted sunscreens could increase the use of SPF among individuals with darker skinAvoiding Laser and Energy-Based Device Complications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/avoiding-laser-and-energy-based-device-complications/20564/Knowing how to avoid and effectively manage potential complications is key to success.Focusing on Patient Education in Atopic Dermatitis
https://practicaldermatology.com/topics/practice-management/focusing-on-patient-education-in-atopic-dermatitis/20661/Patients of all ages have atopic dermatitis, and they seek education and support from their dermatologists.FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis BioteherapuAre You Taking Advantage of Two Everyday Tax-Favored Assets?
https://practicaldermatology.com/topics/practice-management/are-you-taking-advantage-of-two-everyday-tax-favored-assets/23229/Are you taking advantage of two everyday tax-favored assets?DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-counterfeit-botox-cases-widen-new-hs-treatment-approved-europe/24419/In this episode of DermwireTV, the use of counterfeit Botox continues to widen; a first-of-its-kind drug is approved in Europe for hidradenitis suppurativa; and the PA Perspective series provides tips for training and onboarding in a new practice.